Read More

Veru Announces UK’s Medicines and Healthcare Products Regulatory Agency Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients

Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced

VERU

Read More

6 Stocks To Watch As The World Health Organization Declares Monkeypox Outbreak A Global Emergency

The World Health Organization (WHO) on Saturday declared the monkeypox outbreak a global emergency, its highest level of alert. WHO Director-General Tedros Adhanom Ghebreyesus said more than 16,000 cases in more than 75 countries have now been reported around the world.

BVRNY